Journal of Cancer Research and Therapeutics Close
 

Figure 3: A 65-year-old, male patient with hepatocellular carcinoma tumor (6.7cm × 5.8cm) located in the S6 who received MWA alone. The tumor was detected on a contrast-enhanced ultrasound image (a) and verified on a magnetic resonance (MR) image as hyperenhancement in the arterial phase (b); MWA was performed with four insertions with under ultrasound-guidance (c); the ablation was considered complete when there is absence of enhancement in the arterial phase on the MR image 1 month after ablation (d), and the ablation zone gradually shrunk 3 months after ablation (e) (yellow arrow)

Figure 3: A 65-year-old, male patient with hepatocellular carcinoma tumor (6.7cm × 5.8cm) located in the S6 who received MWA alone. The tumor was detected on a contrast-enhanced ultrasound image (a) and verified on a magnetic resonance (MR) image as hyperenhancement in the arterial phase (b); MWA was performed with four insertions with under ultrasound-guidance (c); the ablation was considered complete when there is absence of enhancement in the arterial phase on the MR image 1 month after ablation (d), and the ablation zone gradually shrunk 3 months after ablation (e) (yellow arrow)